Skip to main content

Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA.

Little SE, Vuononvirta R, Reis-Filho JS, Natrajan R, Iravani M, Fenwick K, Mackay A, Ashworth A, Pritchard-Jones K, Jones C

Publication: Genomics (2006) • Vol 87 • Page 298PMID: 16271290View on PubMed

Purpose

Comparative analysis of genomic amplification and subsequent array CGH (aCGH) analysis of formalin fixed paraffin embedded (FFPE) tissue using two different genomic DNA amplification techniques, GenomePlex and degenerate oligonucleotide PCR (DOP).

Conclusion

Although GenomePlex products were slightly shorter and amplification was less efficient compared to DOP generated products, aCGH analyses produced reliable results and displayed no evidence of biased amplification. aCGH analysis of DOP generated products was variable among cases and within a case and displayed evidence of biased amplification.

Studies (4)

Purpose

Comparative analysis of WGA by DOP and GenomePlex using FFPE and frozen specimens.

Summary of Findings

WGA using fresh tissue, compared to FFPE specimens, produced more reliable results with a greater amplification efficiency for both methods analyzed, although GenomePlex yielded more product that DOP. For FFPE specimens, GenomePlex amplification resulted in shorter products (800 bp vs 1 kb) and reduced amplification efficiency compared to DOP. Further, in FFPE specimens, DOP amplification was more consistent across samples compared to GenomePlex (85 vs 58%).

  • Biospecimens

    TissueKidney
  • Preservation Types

    FormalinFrozen
  • Diagnoses

    NeoplasticOther
  • Platforms

    DNAArray CGH
    DNAElectrophoresis
    DNASpectrophotometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen PreservationType of fixation/preservation
    Formalin (buffered)
    Snap frozen
    Array CGH SpecificNucleic acid amplification
    DOP
    GenomePlex